Pharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
It's time for pharmacies to move into the future: Industry 4.0.
Queueing theory can help pharmacy managers control lines, wait times, and staffing issues.
Pharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
The FDA recently approved cannabidiol oral solution to treat seizures.
Being recognized as a BCPP brings professional recognition and credibility as an expert in psychopharmacology and behavioral health matters.
In this month's peer-reviewed article, learn more about the illness affecting millions.
In this month's peer-reviewed article, learn more about the illness affecting millions.
In this month's peer-reviewed article, learn more about the illness affecting millions.
AACP offers a rebuttal to a Drug Topics opinion article.
With 2016 well underway, pharmacies of all sizes should review recent regulatory updates to ensure compliance with rules already in effect, and preparation for those to be implemented soon. Three, in particular, warrant a close look.
Understanding headaches and their various treatment options can help pharmacists counsel patients at the counter.
Rolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.
New developments in cancer treatment require medication experts-here's how you can become that expert.
Analysts have forecasted the market for NASH drugs could reach $20 billion by 2025.
An over-the-counter (OTC) progestin only pill (POP) could potentially reduce the overall number of unintended pregnancies in the United States.
Xadago has been approved as a supplementary medication for patients with Parkinson's disease who are having "off" episodes or whose disease is progressing.
The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
A high performing Pharmacy Services Administrative Organization (PSAO) actualizes its value proposition to its participating pharmacies by entering into viable strategic partnerships that add value to an independent pharmacy’s workflow processes.
FDA approved ixazomib (Ninlaro, Takeda) in combination with lenalidomide and dexamethasone
Delafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.
Entresto® is a newly approved combination of sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker (ARB) for patients who have chronic heart failure NYHA Class II-IV and reduced ejection fraction.